Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hörl WH[au]:

Search results

Items: 1 to 50 of 583

1.

Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease.

Haider DG, Sauter T, Lindner G, Masghati S, Peric S, Friedl A, Wolzt M, Hörl WH, Soleiman A, Exadaktylos A, Fuhrmann V.

Kidney Blood Press Res. 2015;40(6):630-7. doi: 10.1159/000368539. Epub 2015 Dec 17.

2.

Increased chemokine excretion in patients suffering from chronic kidney disease.

Lebherz-Eichinger D, Klaus DA, Reiter T, Hörl WH, Haas M, Ankersmit HJ, Krenn CG, Roth GA.

Transl Res. 2014 Dec;164(6):433-43.e1-2. doi: 10.1016/j.trsl.2014.07.004. Epub 2014 Aug 7.

PMID:
25168017
3.

Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.

Bielesz BO, Hecking M, Plischke M, Cejka D, Kieweg H, Haas M, Marculescu R, Hörl WH, Bieglmayer C, Sunder-Plassmann G.

Clin Biochem. 2014 Sep;47(13-14):1316-9. doi: 10.1016/j.clinbiochem.2014.06.009. Epub 2014 Jun 21.

PMID:
24956265
4.

Kidney biopsy results versus clinical parameters on mortality and ESRD progression in 2687 patients with glomerulonephritis.

Haider DG, Masghati S, Goliasch G, Mouhieddine M, Wolzt M, Fuhrmann V, Hörl WH, Kaider A, Soleiman A.

Eur J Clin Invest. 2014 Jun;44(6):578-86. doi: 10.1111/eci.12274.

PMID:
24749685
5.

Dialysate sodium prescription and blood pressure in hemodialysis patients.

Hecking M, Karaboyas A, Rayner H, Saran R, Sen A, Inaba M, Bommer J, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK.

Am J Hypertens. 2014 Sep;27(9):1160-9. doi: 10.1093/ajh/hpu040. Epub 2014 Mar 20.

PMID:
24651636
6.

Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?

Haider DG, Masghati S, Goliasch G, Fuhrmann V, Soleiman A, Wolzt M, Baierl A, Druml W, Hörl WH.

J Nephrol. 2014 Dec;27(6):643-51. doi: 10.1007/s40620-014-0074-z. Epub 2014 Mar 8.

PMID:
24609889
7.

Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status.

Antlanger M, Hecking M, Haidinger M, Werzowa J, Kovarik JJ, Paul G, Eigner M, Bonderman D, Hörl WH, Säemann MD.

BMC Nephrol. 2013 Dec 2;14:266. doi: 10.1186/1471-2369-14-266.

8.

Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C.

Hörl WH, Schmidt A.

Nephrol Dial Transplant. 2014 Jun;29(6):1141-4. doi: 10.1093/ndt/gft467. Epub 2013 Nov 27.

PMID:
24286977
9.

[Peritoneal dialysis - an alternative to hemodialysis in the center].

Vychytil A, Hörl WH.

Wien Med Wochenschr. 2013 Jun;163(11-12):253-4. German. No abstract available.

PMID:
24000394
10.

Significance of interdialytic weight gain versus chronic volume overload: consensus opinion.

Hecking M, Karaboyas A, Antlanger M, Saran R, Wizemann V, Chazot C, Rayner H, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Moissl U, Kotanko P, Levin NW, Säemann MD, Kalantar-Zadeh K, Port FK, Wabel P.

Am J Nephrol. 2013;38(1):78-90. doi: 10.1159/000353104. Epub 2013 Jul 6.

11.

Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).

Gaggl M, Cejka D, Plischke M, Heinze G, Fraunschiel M, Schmidt A, Hörl WH, Sunder-Plassmann G.

Trials. 2013 Jul 4;14:196. doi: 10.1186/1745-6215-14-196.

12.

Peritonealdialyse - eine Alternative zur Hämodialyse im Zentrum.

Vychytil A, Hörl WH.

Wien Med Wochenschr. 2013 Jun 25. [Epub ahead of print] German. No abstract available.

PMID:
23797683
13.

Glucose metabolism after renal transplantation.

Hecking M, Kainz A, Werzowa J, Haidinger M, Döller D, Tura A, Karaboyas A, Hörl WH, Wolzt M, Sharif A, Roden M, Moro E, Pacini G, Port FK, Säemann MD.

Diabetes Care. 2013 Sep;36(9):2763-71. doi: 10.2337/dc12-2441. Epub 2013 May 8.

14.

Dialysis: A step towards making online haemodiafiltration a gold standard.

Locatelli F, Hörl WH.

Nat Rev Nephrol. 2013 Jun;9(6):316-8. doi: 10.1038/nrneph.2013.75. Epub 2013 Apr 16. No abstract available.

PMID:
23591445
15.

Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature.

Haidinger M, Werzowa J, Kain R, Antlanger M, Hecking M, Pfaffenberger S, Mascherbauer J, Gremmel T, Gilbertson JA, Rowczenio D, Weichhart T, Kopecky C, Hörl WH, Hawkins PN, Säemann MD.

Amyloid. 2013 Jun;20(2):72-9. doi: 10.3109/13506129.2013.781998. Epub 2013 Apr 3.

PMID:
23551149
16.

Cinacalcet effect on polymorphonuclear leucocytes of kidney transplant patients.

Cohen G, Raupachova J, Borchhardt K, Hörl WH.

Eur J Clin Invest. 2013 May;43(5):476-82. doi: 10.1111/eci.12075. Epub 2013 Mar 25.

PMID:
23521420
17.

Anaemia management and mortality risk in chronic kidney disease.

Hörl WH.

Nat Rev Nephrol. 2013 May;9(5):291-301. doi: 10.1038/nrneph.2013.21. Epub 2013 Feb 26. Review.

PMID:
23438972
18.
19.

Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Hecking M, Werzowa J, Haidinger M, Hörl WH, Pascual J, Budde K, Luan FL, Ojo A, de Vries AP, Porrini E, Pacini G, Port FK, Sharif A, Säemann MD; European-New-Onset Diabetes After Transplantation Working Group.

Nephrol Dial Transplant. 2013 Mar;28(3):550-66. doi: 10.1093/ndt/gfs583. Epub 2013 Jan 17.

20.

p38α senses environmental stress to control innate immune responses via mechanistic target of rapamycin.

Katholnig K, Kaltenecker CC, Hayakawa H, Rosner M, Lassnig C, Zlabinger GJ, Gaestel M, Müller M, Hengstschläger M, Hörl WH, Park JM, Säemann MD, Weichhart T.

J Immunol. 2013 Feb 15;190(4):1519-27. doi: 10.4049/jimmunol.1202683. Epub 2013 Jan 11.

21.

The uraemic toxin phenylacetic acid contributes to inflammation by priming polymorphonuclear leucocytes.

Cohen G, Raupachova J, Hörl WH.

Nephrol Dial Transplant. 2013 Feb;28(2):421-9. doi: 10.1093/ndt/gfs454. Epub 2012 Dec 9.

PMID:
23229930
22.

Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients.

Hecking M, Kainz A, Bielesz B, Plischke M, Beilhack G, Hörl WH, Sunder-Plassmann G, Bieglmayer C.

Clin Biochem. 2012 Dec;45(18):1645-51. doi: 10.1016/j.clinbiochem.2012.08.006. Epub 2012 Aug 11.

23.

Immune dysfunction in uremia—an update.

Cohen G, Hörl WH.

Toxins (Basel). 2012 Oct 24;4(11):962-90. doi: 10.3390/toxins4110962. Review.

24.

Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.

Bartel G, Wahrmann M, Schwaiger E, Kikić Ž, Winzer C, Hörl WH, Mühlbacher F, Hoke M, Zlabinger GJ, Regele H, Böhmig GA.

Transpl Int. 2013 Feb;26(2):121-30. doi: 10.1111/tri.12000. Epub 2012 Nov 12.

25.

Modified solid-phase alloantibody detection for improved crossmatch prediction.

Wahrmann M, Hlavin G, Fischer G, Marinova L, Schwaiger E, Hörl WH, Zlabinger GJ, Körmöczi GF, König F, Böhmig GA.

Hum Immunol. 2013 Jan;74(1):32-40. doi: 10.1016/j.humimm.2012.10.012. Epub 2012 Oct 13.

PMID:
23073293
26.

No association of angiotensin-converting enzyme inhibitor or angiotensin 2 receptor blocker intake with acute kidney injury in patients undergoing kidney biopsy.

Friedl A, Peric S, Masghati S, Wolzt M, Hörl WH, Soleiman A, Fuhrmann V, Haider DG.

Kidney Blood Press Res. 2012;35(6):558-60. doi: 10.1159/000339707. Epub 2012 Aug 8.

27.

Lisinopril pharmacokinetics and erythropoietin requirement in haemodialysis patients.

Winnicki W, Prehslauer A, Kletzmayr J, Herkner H, Sunder-Plassmann G, Brunner M, Hörl WH, Sengoelge G.

Eur J Clin Invest. 2012 Oct;42(10):1087-93. doi: 10.1111/j.1365-2362.2012.02699.x. Epub 2012 Jul 28.

PMID:
22845880
28.

Prospective multicenter study of HX575 (biosimilar epoetin-α) in patients with chronic kidney disease applying a target hemoglobin of 10--12 g/dl.

Hörl WH, Locatelli F, Haag-Weber M, Ode M, Roth K; Epo-PASS study group.

Clin Nephrol. 2012 Jul;78(1):24-32.

PMID:
22732334
29.

Kidney biopsy in patients with glomerulonephritis: is the earlier the better?

Haider DG, Friedl A, Peric S, Wiesinger GF, Wolzt M, Prosenz J, Fischer H, Hörl WH, Soleiman A, Fuhrmann V.

BMC Nephrol. 2012 Jun 8;13:34. doi: 10.1186/1471-2369-13-34.

30.

Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial.

Hecking M, Antlanger M, Winnicki W, Reiter T, Werzowa J, Haidinger M, Weichhart T, Polaschegg HD, Josten P, Exner I, Lorenz-Turnheim K, Eigner M, Paul G, Klauser-Braun R, Hörl WH, Sunder-Plassmann G, Säemann MD.

Trials. 2012 Jun 8;13:79. doi: 10.1186/1745-6215-13-79.

31.

CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages.

Poglitsch M, Weichhart T, Hecking M, Werzowa J, Katholnig K, Antlanger M, Krmpotic A, Jonjic S, Hörl WH, Zlabinger GJ, Puchhammer E, Säemann MD.

Am J Transplant. 2012 Jun;12(6):1458-68. doi: 10.1111/j.1600-6143.2012.04002.x. Epub 2012 Mar 5.

32.

Early basal insulin therapy decreases new-onset diabetes after renal transplantation.

Hecking M, Haidinger M, Döller D, Werzowa J, Tura A, Zhang J, Tekoglu H, Pleiner J, Wrba T, Rasoul-Rockenschaub S, Mühlbacher F, Schmaldienst S, Druml W, Hörl WH, Krebs M, Wolzt M, Pacini G, Port FK, Säemann MD.

J Am Soc Nephrol. 2012 Apr;23(4):739-49. doi: 10.1681/ASN.2011080835. Epub 2012 Feb 16.

33.

Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights.

Macdougall IC, Roger SD, de Francisco A, Goldsmith DJ, Schellekens H, Ebbers H, Jelkmann W, London G, Casadevall N, Hörl WH, Kemeny DM, Pollock C.

Kidney Int. 2012 Apr;81(8):727-32. doi: 10.1038/ki.2011.500. Epub 2012 Feb 15. Review.

34.

Serum amyloid A in uremic HDL promotes inflammation.

Weichhart T, Kopecky C, Kubicek M, Haidinger M, Döller D, Katholnig K, Suarna C, Eller P, Tölle M, Gerner C, Zlabinger GJ, van der Giet M, Hörl WH, Stocker R, Säemann MD.

J Am Soc Nephrol. 2012 May;23(5):934-47. doi: 10.1681/ASN.2011070668. Epub 2012 Jan 26.

35.
36.

Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure.

Plischke M, Neuhold S, Adlbrecht C, Bielesz B, Shayganfar S, Bieglmayer C, Szekeres T, Hörl WH, Strunk G, Vavken P, Pacher R, Hülsmann M.

Eur J Clin Invest. 2012 Jun;42(6):649-56. doi: 10.1111/j.1365-2362.2011.02631.x. Epub 2011 Dec 13.

PMID:
22150123
37.

Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality.

Hecking M, Karaboyas A, Saran R, Sen A, Inaba M, Rayner H, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK.

Clin J Am Soc Nephrol. 2012 Jan;7(1):92-100. doi: 10.2215/CJN.05440611. Epub 2011 Nov 3.

38.

HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease.

Lebherz-Eichinger D, Ankersmit HJ, Hacker S, Hetz H, Kimberger O, Schmidt EM, Reiter T, Hörl WH, Haas M, Krenn CG, Roth GA.

Clin Chim Acta. 2012 Jan 18;413(1-2):282-6. doi: 10.1016/j.cca.2011.10.010. Epub 2011 Oct 18.

PMID:
22032827
39.

A transient improvement in renal function occurs after ischemic stroke.

Haider DG, Ferrari J, Mittermayer F, Wolzt M, Hörl WH, Lalouschek W, Lang W.

Ren Fail. 2012;34(1):7-12. doi: 10.3109/0886022X.2011.623439. Epub 2011 Oct 25.

PMID:
22023107
40.

Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Hecking M, Karaboyas A, Saran R, Sen A, Hörl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK.

Am J Kidney Dis. 2012 Feb;59(2):238-48. doi: 10.1053/j.ajkd.2011.07.013. Epub 2011 Sep 23.

PMID:
21944663
41.

Kidney biopsy in patients with diabetes mellitus.

Haider DG, Peric S, Friedl A, Fuhrmann V, Wolzt M, Hörl WH, Soleiman A.

Clin Nephrol. 2011 Sep;76(3):180-5.

PMID:
21888854
42.

[Urinary tract infections].

Hörl WH.

Internist (Berl). 2011 Sep;52(9):1026, 1028-31. doi: 10.1007/s00108-011-2861-0. Review. German.

PMID:
21850538
43.

Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America.

Bailie GR, Hörl WH, Verhoef JJ.

Arzneimittelforschung. 2011;61(5):267-75. doi: 10.1055/s-0031-1296198.

PMID:
21755809
44.

Gender and living donor kidney transplantation.

Khalifeh N, Hörl WH.

Wien Med Wochenschr. 2011 Mar;161(5-6):124-7. doi: 10.1007/s10354-011-0895-5.

PMID:
21461802
45.

Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.

Weichhart T, Haidinger M, Katholnig K, Kopecky C, Poglitsch M, Lassnig C, Rosner M, Zlabinger GJ, Hengstschläger M, Müller M, Hörl WH, Säemann MD.

Blood. 2011 Apr 21;117(16):4273-83. doi: 10.1182/blood-2010-09-310888. Epub 2011 Mar 2.

PMID:
21368289
46.

Effect of leptin on polymorphonuclear leucocyte functions in healthy subjects and haemodialysis patients.

Cohen G, Raupachova J, Ilic D, Werzowa J, Hörl WH.

Nephrol Dial Transplant. 2011 Jul;26(7):2271-81. doi: 10.1093/ndt/gfq731. Epub 2011 Jan 7.

47.

Increased total cytokeratin-18 serum and urine levels in chronic kidney disease.

Roth GA, Lebherz-Eichinger D, Ankersmit HJ, Hacker S, Hetz H, Vukovich T, Perne A, Reiter T, Farr A, Hörl WH, Haas M, Krenn CG.

Clin Chim Acta. 2011 Apr 11;412(9-10):713-7. doi: 10.1016/j.cca.2010.12.030. Epub 2010 Dec 31.

PMID:
21195700
48.

Sodium setpoint and sodium gradient: influence on plasma sodium change and weight gain.

Hecking M, Kainz A, Hörl WH, Herkner H, Sunder-Plassmann G.

Am J Nephrol. 2011;33(1):39-48. doi: 10.1159/000322572. Epub 2010 Dec 11.

PMID:
21160174
49.

A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation.

Haidinger M, Werzowa J, Voigt HC, Pleiner J, Stemer G, Hecking M, Döller D, Hörl WH, Weichhart T, Säemann MD.

Trials. 2010 Oct 6;11:91. doi: 10.1186/1745-6215-11-91.

50.

A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation.

Haidinger M, Poglitsch M, Geyeregger R, Kasturi S, Zeyda M, Zlabinger GJ, Pulendran B, Hörl WH, Säemann MD, Weichhart T.

J Immunol. 2010 Oct 1;185(7):3919-31. doi: 10.4049/jimmunol.1000296. Epub 2010 Aug 30.

Supplemental Content

Support Center